To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03820830
Title Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer (POLAR)
Acronym POLAR
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors International Breast Cancer Study Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | HUN | FRA | ESP | CHE | AUT

Facility Status City State Zip Country Details
Medizinische Universität Graz (MUG) Graz Austria Details
Medizinische Universität Innsbruck - Univ.-Klinik f. Frauenheilkunde Innsbruck Austria Details
Uniklinikum Salzburg Salzburg Austria Details
MUW - Universitätsklinik für Innere Medizin Vienna Austria Details
Institut Sainte Catherine Avignon 84918 France Details
Institut Bergonie Bordeaux 33076 France Details
Polyclinique Bordeaux Nord Bordeaux 333000 France Details
Centre Francois Baclesse Caen 14000 France Details
Cêntre Hospitaler de Cholet Cholet 49300 France Details
Centre Georges François Leclerc Dijon 21079 France Details
Centre Hospitalier Universitaire de Limoges Limoges 87000 France Details
Groupe hospitalier de Bretagne Sud, Hôpital du Scorff Lorient France Details
Centre Leon Berard Lyon 69008 France Details
ICM Val d'Aurelle Montpellier 34298 France Details
Centre Antoine Lacassagne Nice 06189 France Details
Centre Paul Strauss Strasbourg France Details
Institut Claudius Regaud Toulouse 31100 France Details
Gustave Roussy Villejuif 94800 France Details
National Institute of Oncology Budapest Hungary Details
Cro Irccs Aviano Italy Details
ASST Papa Giovanni XXIII Bergamo Italy Details
PO Antonio Perrino Brindisi Brindisi Italy Details
Istituto scientifico Romagnolo per lo studio e la cura Meldola Italy Details
Istituto Europeo di Oncologia Milan Italy Details
AOU Maggiore Della Carita, University of Eastern Piedmont Novara Italy Details
Azienda Ospedaliero-Universitaria di Parma Parma Italy Details
Istituti Clinici Scientifici Maugeri Pavia Italy Details
Ospedale S. Stefano Prato Italy Details
U.O. Oncologia, Ospedale Infermi Rimini Italy Details
Hospital Universitario de Canarias San Cristóbal de La Laguna Tenerife Spain Details
Hospital General Universitario de Alicante Alicante Spain Details
Hospital Universitario Vall d´Hebrón Barcelona Spain Details
Instituto Catalan de Oncologia L´Hospitalet Barcelona Spain Details
Hospital de Basurto Bilbao Spain Details
Institut Català d´Oncología (ICO) Girona Spain Details
Hospital Universitario de La Coruña La Coruna Spain Details
Hospital Universitario 12 de Octubre Madrid Spain Details
HU Ramón y Cajal Madrid Spain Details
Hospital Virgen de la Victoria Málaga Spain Details
Hospital Virgen de la Macarena Sevilla Spain Details
Instituto Valenciano de Oncología (IVO) Valencia Spain Details
Hospital Universitario Río Hortega Valladolid Spain Details
Hospital Universitario Miguel Servet Zaragoza Spain Details
Kantonsspital Baden Baden Switzerland Details
Brustzentrum Basel Bethesda Spital Basel Switzerland Details
Inselspital Bern Bern Switzerland Details
Centre du Sein Fribourg Fribourg Switzerland Details
Fondazione Oncologia Lago Maggiore Locarno Switzerland Details
Kouros Moccia Oncologia Locarno Switzerland Details
Luzerner Kantonsspital Luzern Switzerland Details
Kantonsspital Winterthur Winterthur Switzerland Details
BZ Bethanien Zürich 8001 Switzerland Details
Brust-Zentrum AG Zürich Zürich Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field